Drug Type Natural Killer Cell Therapies |
Synonyms PANK Therapy(Guangdong Xiankangda Biotechnology) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-small cell lung cancer stage IIIA | Phase 2 | - | 18 Jun 2025 | |
Solid tumor | Phase 1 | China | 18 Feb 2024 | |
Hepatocellular Carcinoma | Preclinical | United States | 15 May 2025 |